Drugs / Selected CD 133+ cells
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00694642 Comparator | May 2008 → May 2009 | coronary artery disorder | Pilar Jimenez Quevedo | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Selected CD 133+ cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00694642 ↗ |
| Modality | Cell therapy | “autologous endothelial progenitor cells CD 133” NCT00694642 ↗ |
| Route | Other | “Transendocardial injection of selected CD133+cells” NCT00694642 ↗ |